Xvivo Perfusion Q3’20: First impression
Redeyes first impressions on the Q3 results. Sales came in slightly higher than we expected at SEK 42. 7m vs. our SEK 40.
2m. The gross margin was a tad higher than expected at 78% vs. our expectation of 76.
5%. There are relatively small deviations considering the low visibility at present.